Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Instil Bio Inc. (TIL:NASDAQ), powered by AI.
Instil Bio Inc. is currently trading at $7.61. View real-time AI analysis on Alpha Lenz.
View the latest insider trading data for Instil Bio Inc. on Alpha Lenz.
View Instil Bio Inc.'s valuation metrics on Alpha Lenz.
“Instil Bio Inc.'s ROE is -50.4%. Explore profitability and growth together.”
Ask for details →Instil Bio Inc. is a biotechnology company centered on developing therapies in the field of cell therapy for cancer treatment. The company's primary focus is on utilizing tumor-infiltrating lymphocytes (TILs) to create innovative treatments for patients suffering from a variety of cancer types. Instil Bio harnesses the power of the patient's immune system by engineering and amplifying these TILs to target and combat cancer cells more effectively. The biotechnology sector, which Instil Bio is a part of, plays a critical role in advancing medical science and providing solutions for previously challenging or untreatable medical conditions. Through its work in cell therapy, Instil Bio is positioned within the burgeoning personalized medicine market, which aims to offer more tailored and effective treatment options. Established in the rapidly evolving biotech landscape, Instil Bio contributes to the exploration and application of cutting-edge therapies designed to improve patient outcomes by offering alternative solutions to conventional cancer treatments.
“Instil Bio Inc.'s ROE is -50.4%. Explore profitability and growth together.”
Ask for details →Instil Bio Inc. (ticker: TIL) is a company listed on NASDAQ in the Healthcare sector (Biotechnology). It has approximately 14 employees.
The current price is $7.61 with a P/E ratio of -x and P/B of -x.
ROE is -50.39%.